Keyphrases
Disseminated Tumor Cells
100%
Radiation-induced Bystander Effect
100%
Radium-223 Therapy
100%
Bystander Effect
66%
Radium-223
66%
Alpha Particles
44%
Bystander Cells
22%
Absorbed Dose
22%
Metastatic Disease
22%
Bystander
22%
Radionuclide Therapy
22%
Bone Marrow
22%
Alpha Radiation
22%
Clinical Setting
11%
Developing Strategy
11%
Lymph Node
11%
Breast Cancer Survivors
11%
Bone Tissue
11%
Organ Culture
11%
Cell Killing
11%
Cell Population
11%
Lymphoid Organs
11%
Radiotherapy Treatment
11%
Non-target Effects
11%
Bone Surface
11%
Surrounding Tissues
11%
Invasion Rate
11%
Proliferation Rate
11%
Radionuclides
11%
Biological Changes
11%
Migration Rate
11%
Breast Cancer
11%
Dose Effect
11%
Significant Risk Factors
11%
Radiotherapy
11%
Direct Response
11%
Micrometastasis
11%
Radiosensitivity
11%
Cancer Cells
11%
Human Breast Cancer Cells
11%
Life Expectancy
11%
Neighboring Cells
11%
Small-scale Dosimetry
11%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
11%
In Vivo Model
11%
Adjuvant Therapy
11%
Primary Tumor
11%
Frontline Therapy
11%
Proliferation Migration
11%
Radiation Dose
11%
Therapeutic Role
11%
Medicine and Dentistry
Metastatic Carcinoma
100%
Bystander Effect
100%
Breast Cancer
27%
Absorbed Dose
18%
Radionuclide Therapy
18%
Cancer Cell
18%
Radiation Therapy
18%
Micrometastasis
9%
Radium Chloride Ra 223
9%
Malignant Neoplasm
9%
Life Expectancy
9%
Cell Killing
9%
Dosimetry
9%
Adjuvant Therapy
9%
Recurrent Disease
9%
Prostate Cancer
9%
Organ Culture
9%
Cell Population
9%
Lymph Node
9%
Radiosensitivity
9%
Radioisotope
9%
Primary Tumor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Metastasis
100%
Radioisotope
27%
Breast Cancer
27%
Malignant Neoplasm
18%
Life Expectancy
9%
Micrometastasis
9%
Recurrent Disease
9%
Prostate Cancer
9%
Dosimetry
9%
Radium Chloride Ra 223
9%
Primary Tumor
9%